Abstract:The field of anticancer nanomedicine seeks to boost the arsenal’s exploitation with intelligent performance. One opportunistic choice comes from the fabrication of amphiphilic polymer micelles that are reversibly crosslinked. Here, hydrogen-bond (H-bond)-driven core-crosslinked supramolecular polymer micelles (FUS/ICG@PEDD) are constructed, co-loading α,ω-functionalized symmetrical H-bonding prodrug 5-fluorouracil-acetic acid–SS–5-fluorouracil-acetic acid (FUS) and a dual photothermal/photodynamic agent (indocyanine green, ICG). Such core-crosslinked nanomedicine is characterized by enhanced drug loading content, crosslinking-prompted stability, pH-responsive charge reversal, and smart drug release, which can facilitate the engineering of synergistic chemo/photothermal/photodynamic therapies (CT/PTT/PDT). To do so, an amphiphilic diblock copolymer, PEG-b-P(DAPA-co-DEAEMA) (denoted as PEDD), is developed to serve as a drug delivery vehicle, with hydrophilic PEG [poly(ethylene glycol)] and hydrophobic P(DAPA-co-DEAEMA) [poly(diaminopyridine acrylamide-co-2-(diethylamino)ethyl methacrylate], bearing randomly dispersed dual functionalities: pH-responsive charge-reversal DEAEMA and H-bonding DAP motifs. Thanks to the specific DAP/FUS H-bonding interactions and two-terminal FU structure of the prodrug, core-crosslinked nanomedicine FUS/ICG@PEDD is thus enabled. In vitro and in vivo investigations indeed reveal remarkable antitumor efficacy. We believe that such H-bonded nanomedicines can fuel the development of intelligent nanomedicines with value in cancer therapy.

Facile Preparation of Phospholipid-Amorphous Calcium Carbonate Hybrid Nanoparticles: Toward Controllable Burst Drug Release and Enhanced Tumor Penetration (vol 54, Pg 13080, 2018)

Correction: Facile Preparation of Phospholipid-Amorphous Calcium Carbonate Hybrid Nanoparticles: Toward Controllable Burst Drug Release and Enhanced Tumor Penetration.

Correction: Synthetic Ultra-Long Chain Fatty Acyl Based Amphiphilic Lipids As a Dual Function Excipient for the Production of Surfactant-Free Solid Lipid Nanoparticles (Sf-Slns): a Physico-Chemical Study

Taking Advantage of the Disadvantage: Employing the High Aqueous Instability of Amorphous Calcium Carbonate to Realize Burst Drug Release Within Cancer Cells

Size-Controlled Preparation and Behavior Study of Phospholipid-Calcium Carbonate Hybrid Nanoparticles.

Correction: Oral delivery of a platinum anticancer drug using lipid assisted polymeric nanoparticles

Correction: Highly Penetrative Liposome Nanomedicine Generated by a Biomimetic Strategy for Enhanced Cancer Chemotherapy.

Correction: Preparation of Electrospray ALG/PDA–PVP Nanocomposites and Their Application in Cancer Therapy

Correction to "Enhancing the Efficacy and Safety of Doxorubicin against Hepatocellular Carcinoma through a Modular Assembly Approach: The Combination of Polymeric Prodrug Design, Nanoparticle Encapsulation, and Cancer Cell-Specific Drug Targeting"

Corrigendum to "Emulsifying Lipiodol with pH-Sensitive DOX@HmA nanoparticles for hepatocellular carcinoma TACE treatment eliminate metastasis" Mater. Today Bio, 23, 2023, 100873, ISSN 2590-0064

Correction: A highly antibacterial polymeric hybrid micelle with efficiently targeted anticancer siRNA delivery and anti-infection in vitro/in vivo

Mitoxantrone-preloaded water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles for targeted and effective cancer therapy.

Ultrasonic Controlled Morphology Transformation of Hollow Calcium Phosphate Nanospheres: A Smart and Biocompatible Drug Release System

Correction: The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer

Correction: Ci et al. Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer. Pharmaceutics 2019, 11, 15

Correction: Tumor-targeting, enzyme-activated nanoparticles for simultaneous cancer diagnosis and photodynamic therapy

Synthesis and biological evaluation of fluorescent hyaluronic acid modified amorphous calcium phosphate drug carriers for tumor-targeting

Hydrogen-Bond-Driven Core-Crosslinked Supramolecular Micelles with pH/Thermal/Glutathione-Responsive Drug Release toward Enhanced Cancer Therapy

Corrigendum: The Preparation of Hollow Mesoporous Bioglass Nanoparticles With Excellent Drug Delivery Capacity for Bone Tissue Regeneration

A Preloaded Amorphous Calcium Carbonate/Doxorubicin@Silica Nanoreactor for Ph‐responsive Delivery of an Anticancer Drug